T ype I IFNs (IFN-1) are a family of cytokines that signal through a common IFN-a/b receptor (IFNAR) and can have both pro-and anti-inflammatory effects. In addition to enhancing NK, B, and CD8 + T cell activity, IFN-1 can influence CD4 + T cell differentiation and function via effects on dendritic cells (DCs). IFN-1 drives DC activation and maturation (1, 2) , MHC class II expression, and production of IL-12 (3-6) to augment Th1 cell responses. Additionally, IFN-1 can act directly on T cells to inhibit their egress from lymph nodes, thus promoting DC/T cell interactions (7) . Furthermore, IFNAR signaling on T cells activated in peripheral tissues enhances their survival (8) . Consistent with these immune-activating effects, type I IFNs are essential for driving T cell responses to vaccination with adjuvants and are themselves being explored as vaccine adjuvants in humans (9) .
In contrast, IFN-1 can suppress immune responses by several mechanisms and are used to treat multiple sclerosis. For example, IFN-1 can drive the production of anti-inflammatory cytokines, including IL-10, IL-27, and IL-1R antagonist (IL-1RA), from mononuclear phagocytes (MPs) and of regulatory SOCS and PIAS proteins in T cells and MPs (10) (11) (12) (13) (14) . Additionally, IFN-1 can inhibit the secretion of IL-1b both by suppressing pro-IL-1b production and by inhibiting pro-IL-1b cleavage to mature IL-1b by blocking inflammasome activation (15) . Furthermore, IFN-1 can inhibit Th17 cell differentiation by inhibiting IL-1b and osteopontin and by inducing IL-27 production by MPs (13, 16, 17) . Finally, IFN-1 can inhibit inflammatory responses that they promote in other contexts. For example, IFN-1 suppresses IFN-g-induced MHC class II expression, perhaps as a negative feedback mechanism (18) , and high levels can inhibit IL-12 production during certain viral infections (19) . IFN-1 can also either induce or inhibit IFN-g production by NK and T cells depending on the balance of STAT4 and STAT1 signaling, allowing opposing cell-and context-specific effects on immune cells (20) .
The role of IFN-1 in intestinal inflammation is poorly understood. In prior studies of dextran sulfate sodium (DSS)-induced acute colitis in mice, CpG oligodeoxynucleotide administration prevented disease in an IFN-1-and CD11c + cell-dependent manner (21, 22) . Furthermore, IFNAR1 2/2 mice were more susceptible to DSS-induced colitis (22) . Similarly, polyinosinic-polycytidylic acid treatment attenuated T cell-mediated colitis via IFN-1 signaling directly on T cells (23) . Direct treatment of T cells with IFN-1 could also limit their colitogenic potential (24) . Although clinical trials using IFN-1 to treat human inflammatory bowel disease have been met with limited success (25, 26) , a recent genome-wide association study has implicated the locus containing IFNAR in the risk for developing human inflammatory bowel disease (27) . In the present study, we explored the role of endogenous IFN-1 in regulating chronic colitis by using the T cell adoptive transfer model (28) , which more accurately reflects the chronic inflammation of human Crohn's disease (29) . We found a critical role for IFNAR signaling on host innate immune cells in controlling colitis development by regulating T cell accumulation, regulatory T cell (Treg) function, and the production of regulatory cytokines by colon MPs.
Materials and Methods
Mice WT C57BL/6 (CD45.2) mice were purchased from the National Cancer Institute. SJL (CD45.1), IFNAR1
2/2
, and RAG 2/2 mice, all on a C57BL/6 background, were obtained from Taconic Farms bred on contract with the National Institute of Allergy and Infectious Diseases. Double knockout (DKO) mice were generated by crossing RAG 2/2 and IFNAR1 2/2 mice and screening for offspring homozygous for both genes. Foxp3-GFP mice were originally from V. Kuchroo. Toll/IL-1R domain-containing adapterinducing IFN-b (TRIF)
, and their WT control mice were purchased from The Jackson Laboratory. TRIF 2/2 /MyD88 2/2 mice were a gift from A. Sher. All mouse experimental protocols were approved by the National Institute of Allergy and Infectious Diseases Animal Care and Use Committee, and mice were housed under specific pathogen-free conditions in National Institute of Allergy and Infectious Diseases animal facilities.
Abs and reagents
Abs used for staining were against CD4 (RM4-5), CD11b (M1/70), CD11c (N418), CD19 (eBio1D3), CD25 (PC61.5), CD44 (IM7), CD45.1 (A20), CD45.2 (104), CD45RB (C363.16A), CD62L (MEL-14), CD103 (2E7), MHC class II IA/IE (M5/114.15.2), TCRb (H57-597), TCRgd (eBioGL3), F4/80 (BM8), Foxp3 (FJK-16s), IL-17A (eBio17B7), IFN-g (XMG1.2), or isotype controls. All were purchased from eBioscience. Anti-murine IFNAR1 (MAR1-5A3) was purchased from BioLegend. Murine IFN-aA was purchased from PBL Interferon Source. Anakinra (Kineret; Amgen) was provided by Dr. Raphaela Goldbach-Mansky (National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health). hi T cells were labeled with CFSE (10 mM; Invitrogen) according to the manufacturer's protocol prior to i.p. injection. For the anakinra treatment experiments, 1 mg anakinra in PBS was injected i.p. on the same day as the T cell transfer followed by 1 mg daily for 9 additional days. Clinical signs of colitis, including weight loss and diarrhea, were monitored biweekly. H&E-stained sections from the proximal, middle, and distal colon were scored for histopathology as previously described (30) .
Induction of colitis

Generation of bone marrow chimeras
Following 900 rads of gamma radiation, RAG 2/2 mice were i.v. injected with 3 3 10 6 bone marrow (BM) cells from RAG 2/2 or DKO mice. Mice were used for experiments 8 wk later. More than 95% of hematopoietic cells were routinely of donor origin. For colon lamina propria (cLP) cell isolation, colons were rinsed of mucus and feces and cut longitudinally into 2-cm pieces. Colon pieces were incubated in warm HBSS with 10% FCS, 5 mM EDTA, 15 mM HEPES, and 0.015% DTT for 15 min with continuous shaking at 37˚C. Colon pieces were shaken vigorously and washed at least five times or until the supernatant cleared to remove the epithelial cell layer. Colon pieces were then minced and placed into digestion buffer for 1 h with continuous shaking at 37˚C. Colon pieces were mashed through a 40-mm filter. In some cases, the cLP cell suspension was enriched for mononuclear phagocytes using a Nycodenz gradient (Accurate Chemical) according to the manufacturer's instructions as previously described (31) . Specific MP populations were sorted or analyzed by flow cytometry by gating on live lineage (TCRb, TCRgd, CD19) 2 , MHC class II hi , and F4/80 + or CD11c + cells as indicated, and as previously described (31) .
Isolation of mononuclear cell populations
In vitro cell stimulations
Colon or MLN MPs (1 3 10 6 /ml in complete RPMI 1640 media) from steady-state mice were cultured for 24 h with or without FSL-1 (500 ng/ml; InvivoGen), flagellin (1 mg/ml; InvivoGen), anti-IFNAR1 (5 mg/ml), or IFN-aA (500 U/ml) in complete RPMI 1640 media. Cytokine production was detected by multiplex immunoassay (Aushon Biosystems), ELISAs for IL-10 and IL-1RA (R&D Systems), or ELISA for IFN-b (PBL Interferon Source).
cLP cells (1 3 10 6 /ml) from colitic mice were stimulated with PMA (50 ng/ml) and ionomycin (500 ng/ml) in complete RPMI 1640 media. After 2 h, GolgiStop (BD Biosciences) was added and left in culture for an additional 3 h before analysis by flow cytometry.
Quantitative RT-PCR
RNA was extracted using a Qiagen RNeasy Mini Kit, converted to cDNA (qScript cDNA SuperMix [Quanta Biosciences]), and used in a PCR reaction with PerfeCTa qPCR FastMix (Quanta Biosciences), FAM-labeled probes, and primers for genes of interest. Quantitative expression was normalized to transcript levels of GAPDH using the equation 1/2 DCT , where DCT = CT Target 2 CT GAPDH .
Flow cytometry
Cells were stained with Live/Dead-conjugated dye (Invitrogen) and Abs against extracellular markers for 20 min at 4˚C. Intracellular Foxp3 was stained using a Foxp3 intracellular staining kit (eBioscience) per the manufacturer's instructions. Cells were analyzed on an LSR II flow cytometer (BD Biosciences).
Statistical analysis
Body weight curves were analyzed using one-way ANOVA and Bonferroni posttest corrections. In vivo studies using individual mice were analyzed using the nonparametric Mann-Whitney U test. In vitro data using cells pooled from several mice were analyzed using a student t test. Analysis was performed using Prism 5 software (GraphPad Software). A p value , 0.05 was considered statistically significant.
Results
Constitutive type I IFN production is TRIF dependent
Prior studies showed that LP DCs from the small intestine constitutively produce IFN-b (32). FACS-sorted MP subsets from the colon (as gated in Fig. 1A ) also constitutively produced IFN-b ( Fig. 1B-E) . Transcription of IFN-b was independent of the TLR adapter molecule MyD88, but dependent on TRIF, an adapter molecule that mediates signaling by TLR3, TLR4, and intracellular helicases that sense dsRNA (33) . Isolated, cultured colon MPs also constitutively secreted IFN-b in a TRIF-dependent manner (Fig. 1E ).
IFNAR signaling on RAG 2/2 host cells suppresses the induction of colitis
We next explored the role of endogenous IFN-1 in immune homeostasis using the T cell transfer model of colitis (28 and accumulation of CD4 + T cells in the colon (Fig. 2B, 2C ). Although the proportion of pathogenic colon T cells producing IFN-g in RAG 2/2 and DKO mice was similar, the proportion producing IL-17 alone, or producing IL-17 and IFN-g, was higher among T cells from DKO mice (Fig. 2D, 2E ). The proportion of CD4 + T cells expressing Foxp3, however, was equivalent in RAG 2/2 and DKO mice (Fig. 2F ).
IFNAR signaling on RAG 2/2 host hematopoietic cells is required to suppress colitis
Most cells in the body express IFNAR, including both hematopoietic and nonhematopoietic cells. To determine the cell types responsible for the indirect effects of IFNAR signaling on T cell expansion and colitis development, we reconstituted irradiated RAG 2/2 mice with BM from RAG 2/2 or DKO mice. Two weeks after the transfer of WT CD4 + CD45RB hi T cells, DKO BM chimeric mice exhibited rapid weight loss (Fig. 3A) , worse histopathological features (Fig. 3A) , and a greater accumulation of CD4 + T cells in the colon than did RAG 2/2 BM chimeric mice (Fig. 3B) .
No difference was observed in the proportion of cLP CD4 + T cells producing IFN-g between DKO and RAG 2/2 BM chimeric mice, but the percentage of CD4 + T cells from DKO BM chimeric mice producing IL-17 or IL-17 and IFN-g was significantly higher than that from RAG 2/2 BM chimeric mice (Fig. 3C) , consistent with data from DKO recipients (Fig. 2) . Also resembling DKO mice, DKO BM chimeras showed no difference in the proportion of Foxp3 + cells among CD4 + T cells (Fig. 3D) .
Accelerated effector T cell expansion was found in the MLNs in the absence of host IFNAR signaling
The increased accumulation of effector T cells in the cLP of DKO or DKO BM chimeric mice may be due to enhanced priming and proliferation of T cells in mucosal lymphoid organs or to local expansion and/or survival in the cLP. To address this issue, we transferred CFSE-labeled CD4 + CD45RB hi T cells into RAG
or DKO recipients. Seven to 10 d after transfer, before colitis was evident, T cell expansion in the MLNs was greatly enhanced in DKO compared with RAG 2/2 hosts (Fig. 4A, 4E ). Most CD4 + T cells recovered from the MLNs of DKO hosts had undergone rapid proliferation, indicated by complete dilution of CFSE. In contrast, RAG 2/2 recipients had a larger proportion of CD4 + T cells with fewer (none to three) divisions (Fig. 4B) . Proliferating CD4 + T cells recovered from RAG 2/2 recipients expressed CD62L, a marker of naive T cells and of T cells undergoing homeostatic proliferation, whereas the vast majority of CD4 + T cells from DKO recipients expressed low levels of CD62L and high levels of CD44 (Fig. 4C, 4D) , indicative of effector and memory T cells.
Colon mononuclear phagocytes require IFNAR signaling for anti-inflammatory cytokine production
Because the accelerated colitis observed in DKO mice was dependent on a lack of IFNAR signaling on host hematopoietic cells, we next evaluated the role of IFNAR signaling on MPs. We isolated MPs from the cLP of WT and IFNAR1 2/2 mice (as gated in Fig. 1A ). MPs can be further subdivided into distinct populations of macrophages and DCs with specialized functions. F4/80 hi colon macrophages produce high levels of IL-10 and IL-1RA and lower levels of IL-27 whereas CD11c + F4/80 int/lo DC subsets stimulate T cell proliferation and produce proinflammatory cytokines such as IL-12, Il-23, IL-6, TNF-a, and IL-1b. Because the local balance of these regulatory macrophage and stimulatory DC populations could influence immunological homeostasis in the colon (31, 36), we next determined whether the distribution of these distinct MP populations was altered in the absence of IFNAR signaling. However, we did not find a change in either the distribution or level of activation of these populations in the steady-state colon (Supplemental Fig. 1A, 1B) .
We next investigated cytokine production by cLP MPs in WT and IFNAR1 2/2 mice (Fig. 5A ). IFNAR1 2/2 MPs produced significantly lower amounts of the anti-inflammatory cytokine IL-10 either with or without in vitro stimulation with FSL-1 and flagellin, TLR ligands chosen due to the high expression of their receptors, TLR2/6 and TLR5, respectively, on intestinal MPs (31). MPs from IFNAR1 2/2 mice also showed defects in the production of IL-27
and IL-1RA, two other anti-inflammatory cytokines. Constitutive production of IFN-1 was necessary for optimal anti-inflammatory cytokine production, as treatment with an anti-IFNAR1 Ab also decreased IL-10 and IL-1RA production from WT cells (Fig. 5B) . Addition of exogenous IFN-1 did not, however, enhance the production of these cytokines. In contrast, production of the proinflammatory cytokines IL-1a, IL-23, and TNF-a was not affected by IFNAR signaling, although IFNAR1 2/2 MPs produced marginally lower quantities of IL-6 upon FSL-1 stimulation (Fig. 5A ).
Treatment with IL-1RA can reverse accelerated T cell proliferation seen in DKO mice
We next asked whether the defect in anti-inflammatory cytokine production in IFNAR1 2/2 MPs could explain the accelerated colitis.
We initially treated DKO mice transferred WT CD4 + CD45RB hi cells with recombinant IL-10 but were unable to see any effect on colitis development (data not shown). We next treated mice with anakinra, a recombinant form of human IL-1RA used in the treatment of rheumatoid arthritides (37) , which also blocks IL-1 activity in mice (38) hi cells, but it had little effect on T cell expansion in RAG 2/2 mice (Fig. 6A, Supplemental Fig. 2A, 2C ).
The enhanced T cell proliferation in DKO mice may be due to enhanced priming of T cells by DCs in the MLNs. Early after T cell transfer, we found an influx of CD11c the MLNs of DKO mice (Fig. 6B, Supplemental Fig. 2B, 2C) . A similar population of cells also expands in the cLP during inflammation, migrates from the colon tissue to the MLNs, and is capable of priming T cells (31, 39 (Fig. 6B , Supplemental Fig. 2B, 2C) . Thus, IL-1RA may control T cell proliferation indirectly by inhibiting migration of this inflammatory APC population from the cLP to the MLNs, consistent with previous reports that IL-1 signaling directly on CD4 + T cells is dispensable for T cell proliferation in the MLNs in this model of colitis (40) . + CD45RB hi T cell transfer, Tregs were equivalently induced in the MLNs of both mouse strains (Fig. 7A) .
Although DKO mice showed no defect in Treg induction, we next determined whether defects in Treg expansion and/or maintenance were observed in the absence of IFNAR signaling. We cotransferred CD45. + T cells from either mouse strain were able to suppress weight loss, development of histopathology, accumulation of CD4 + T cells in the colon, and production of IFN-g by colon CD4
+ T cells (Supplemental Fig. 3) . Transfer of either genotype Treg enhanced the induction of IL-17-producing CD4 + T cells, as has been shown in other models of in vivo Th17 cell differentiation (44, 45) . We also found an equal percentage of Foxp3 + T cells among total CD4 + T cells, showing that WT and IFNAR1 2/2 Tregs were expanded and maintained equivalently in the lymphopenic environment.
Discussion
Taken together, the data presented in this study indicate for the first time, to our knowledge, a clear indirect role for IFNAR signaling in regulating mucosal T cell responses during colitis. Using the adoptive transfer model, we found a predominant effect of IFN-1 on innate immune cells in the RAG 2/2 host rather than directly on CD4 + CD45RB hi naive T cells or CD4 + CD25 + Tregs to affect their colitogenic or protective properties, respectively ( Fig. 2A, Supplemental Fig. 3 pathogenic upon transfer to RAG-deficient hosts (35) . These results are inconsistent with the present findings, and cannot be easily explained, except to suggest that differences in endogenous commensal bacteria or the possibility of occult viral infection in the absence of IFNAR signaling in some mouse colonies may affect the regulatory potential of CD4 + CD45RB lo T cell populations.
In the present studies, we clearly demonstrate that CD4 + CD25 + CD45RB lo T cells from IFNAR1 2/2 mice suppress clinical disease and IFN-g production by effector T cells (Supplemental Fig. 3 ). We determined that rapid early proliferation of CD4 + T cells in MLNs of DKO mice was followed by accumulation of effector CD4 + T cells in the cLP (Fig. 4) . Rapid proliferation suggests foreign antigenic stimulation and/or "spontaneous proliferation," an IL-7-independent mechanism of proliferation seen in chronic lymphopenic conditions (46) . Slow proliferation, as was exhibited by the T cells transferred into RAG 2/2 mice, is more characteristic of homeostatic proliferation driven by self MHC-peptide ligands, IL-7 and IL-15 (47) . Accordingly, the rapidly proliferating T cells isolated from DKO mice were CD44 hi and CD62L lo , characteristic of effector T cells, whereas the slowly proliferating T cells isolated from RAG 2/2 mice were CD44 lo and CD62L hi , characteristic of naive T cells.
T cell proliferation in the MLNs is most likely driven by migratory DCs. Consistent with this possibility, we found that a population of CD11c int DCs (31) . CX 3 CR1 int cells infiltrate the colon during inflammation in this model (31) and become a migratory population that can prime T cell responses during DSS-induced colitis (39) . Therefore, these data are consistent with a role for host IFNAR signaling in inhibiting the trafficking of monocytederived inflammatory DCs to the MLNs during T cell adoptive transfer colitis.
IL-1a, IL-1b, and TNF-a can each drive the migration of tissueresident DCs to the draining lymph node where they can prime T cells (48, 49) . Although production of these cytokines was not increased from colon MPs from IFNAR1 2/2 mice, IFNAR1
2/2
MPs produced lower levels of IL-1RA, an inhibitor of IL-1 activity (Fig. 5 and data Constitutive IFN-1 signaling also conditioned colon MPs for the optimal production of IL-10 and IL-27 (Fig. 5) . Local production of IL-10 by LP MPs is critical for both the expansion and maintenance of Foxp3 + Tregs in the intestine (41, 51) . We previously identified a subset of colon macrophages that constitutively produce IL-10 via flora-dependent and -independent mechanisms (31) . We demonstrate in this study an essential role for IFNAR signaling on colon MPs in inducing their production of IL-10. IL-27 potentiates IL-10 production by macrophages in response to LPS-induced IFN-1 signaling (52) and inhibits Th17 differentiation (13, 16) . Thus, our finding that T cells transferred into DKO hosts were more likely to differentiate into IL-17-producing subsets may also be due to a lack of IL-27-mediated inhibition of Th17 differentiation. Furthermore, IL-27 was recently shown to be a key cytokine that specifically promotes the development and function of mucosal Tregs (53) . Thus, poor production of IL-27, in addition to IL-10, may be responsible for the impaired maintenance of Tregs in the colon.
Our data also show a more important role for constitutive IFN-1 production in inducing anti-inflammatory cytokines than treatment with exogenous IFN-1. When IFNAR signaling was blocked using a monoclonal neutralizing Ab, FSL-1-induced IL-10 and IL-1RA production was reduced. FSL-1 does not induce IFN-1 (54), suggesting that the IFN-1 found in the in vitro cell stimulations was constitutively produced. Furthermore, exogenous IFN-1 did not augment the production of IL-10 or IL-1RA.
Finally, the fact that DKO BM chimeras (Fig. 3) and RAG
mice treated with anti-IFNAR1 Abs (data not shown) also developed severe and accelerated colitis indicate a microbiomeindependent role for IFN-1 in regulating intestinal inflammatory T cell responses. Because both RAG 2/2 and DKO BM chimeras were created using RAG 2/2 recipients, they were likely to have the same microbiome. Whether alterations in the microbiome are responsible for the more severe disease observed in the DKO mice when compared with the DKO BM chimeric mice is not yet clear and is currently under investigation. Taken together, to our knowledge our studies indicate for the first time that endogenous IFN-1 act on host innate immune cells to induce the production of anti-inflammatory cytokines by intestinal MPs and indirectly regulate the accumulation of both effector and regulatory T cells in the colon during the course of inflammation. The impaired ability of IFNAR1 2/2 colonic MPs to produce IL-10, IL-1RA, and IL-27 in the context of normal production of proinflammatory cytokines provides an explanation for the poor expansion and maintenance of Tregs and enhanced expansion of effector T cells observed in the cLP of DKO mice during colitis. These data also suggest that further studies addressing the factors that drive physiological IFN-1 production and regulate their signaling in the colon will help to elucidate their pleiotropic effects on immune cells and lead to more targeted therapies for colitis and other inflammatory diseases.
